Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Funding
Sign In Sign Up
Night Mode
Calcimimetics and the Secondary Hyperparathyroidism Treatment Market
Calcimimetics have transformed the management of secondary hyperparathyroidism. By mimicking calcium and activating the calcium-sensing receptor on parathyroid cells, these drugs suppress parathyroid hormone production without increasing serum calcium — a significant clinical advantage over older approaches. Calcimimetics are the fastest-growing drug class in the secondary...
0 Comments ·0 Shares ·24 Views ·0 Reviews
Please log in to like, share and comment!